dual glycogen synthase kinase 3/casein kinase 2 modulators (University of Illinois at Chicago/University of Illinois at URBANA-CHAMPAIGN)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual glycogen synthase kinase 3/casein kinase 2 modulators (University of Illinois at Chicago/University of Illinois at URBANA-CHAMPAIGN)
Drug Alias Namedual GSK3/CK2 modulators (University of Illinois at Chicago/University of Illinois at URBANA-CHAMPAIGN)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCasein kinase II modulatorsGlycogen synthase kinase-3 modulators
TargetsGlycogen synthase kinase-3Casein kinase II
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of IllinoisUniversity Of Illinois At Urbana–Champaign
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A